Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines.
第一作者:
Stephen M,Ansell
第一单位:
Division of Hematology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA. ansell.stephen@mayo.edu
作者:
医学主题词
肾上腺皮质激素类(Adrenal Cortex Hormones);抗体, 单克隆(Antibodies, Monoclonal);抗体, 单克隆, 鼠源性(Antibodies, Monoclonal, Murine-Derived);抗肿瘤药(Antineoplastic Agents);血液黏度(Blood Viscosity);药物疗法, 联合(Drug Therapy, Combination);人类(Humans);免疫因子类(Immunologic Factors);血浆去除术(Plasmapheresis);预后(Prognosis);复发(Recurrence);危险因素(Risk Factors);时间因素(Time Factors);治疗结果(Treatment Outcome);Waldenstrom巨球蛋白血症(Waldenstrom Macroglobulinemia)
DOI
10.4065/mcp.2010.0304
PMID
20702770
发布时间
2022-03-30
- 浏览82
Mayo Clinic proceedings
824-33页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



